These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30037283)

  • 41. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H; Kawai N; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevance Vector Machines: Sparse Classification Methods for QSAR.
    Burden FR; Winkler DA
    J Chem Inf Model; 2015 Aug; 55(8):1529-34. PubMed ID: 26158341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
    Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
    Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H; Yao X; Wang C; Han J
    Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
    Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.
    Dao TT; Nguyen PH; Lee HS; Kim E; Park J; Lim SI; Oh WK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):294-8. PubMed ID: 21123068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS; Huang RB; Wei YT; Du LQ; Chou KC
    J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular basis of drug resistance in A/H1N1 virus.
    Vergara-Jaque A; Poblete H; Lee EH; Schulten K; González-Nilo F; Chipot C
    J Chem Inf Model; 2012 Oct; 52(10):2650-6. PubMed ID: 22978683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug-resistant influenza viruses: an overview].
    Hatakeyama S
    Nihon Rinsho; 2010 Sep; 68(9):1671-8. PubMed ID: 20845746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).
    Qin Z; Wang M; Yan A
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2931-2938. PubMed ID: 28501513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.
    Perez-Sautu U; Pozo F; Cuesta I; Monzon S; Calderon A; Gonzalez M; Molinero M; Lopez-Miragaya I; Rey S; Cañizares A; Rodriguez G; Gonzalez-Velasco C; Lackenby A; Casas I
    Euro Surveill; 2014 Jul; 19(27):14-20. PubMed ID: 25033052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
    Dao TT; Dang TT; Nguyen PH; Kim E; Thuong PT; Oh WK
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3688-92. PubMed ID: 22552195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].
    Huang W; Li X; Tan M; Wei H; Cheng Y; Guo J; Wang Z; Xiao N; Wang D; Shu Y
    Bing Du Xue Bao; 2015 Mar; 31(2):152-6. PubMed ID: 26164940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
    Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adaptive variable-weighted support vector machine as optimized by particle swarm optimization algorithm with application of QSAR studies.
    Wen JH; Zhong KJ; Tang LJ; Jiang JH; Wu HL; Shen GL; Yu RQ
    Talanta; 2011 Mar; 84(1):13-8. PubMed ID: 21315891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis.
    Sun J; Cai S; Yan N; Mei H
    Eur J Med Chem; 2010 Mar; 45(3):1008-14. PubMed ID: 19969399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.